Cancer and Minorities (Norma Kanarek, PhD, MPH)

Embed Size (px)

Citation preview

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    1/30

    Cancer and MinoritiesNorma Kanarek, MPH, PhD

    Department of Environmental Health Sciences, JohnsHopkins Bloomberg School of Public Health

    Department of Oncology, Johns Hopkins School ofMedicine

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    2/30

    Cancer Health Disparities

    Differences by among disadvantaged

    groups defined by

    Race Ethnicity

    Sexuality

    Wealth/income

    Gender

    Disability status

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    3/30

    Ways to think about differences

    among population groups Poverty/policies the root cause of

    disparities??

    Differences by cancer site Differences by person, place and time

    Key determinants of health disparities

    Data issues and sources

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    4/30

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    5/30

    Poor Breast Cancer Survival in Blacks

    May Not Be Due to RaceMany factors, including access to health care, could affectoutcome, analysis finds

    WEDNESDAY, June 23 (HealthDay News) -- Underinsured black breast cancer patients haveworse survival outcomes than underinsured white patients, a new U.S. study has found.

    Researchers analyzed the records of 574 breast cancer patients treated at Wishard

    Memorial Hospital in Indianapolis between Jan. 1, 1997 and Feb. 28, 2006, and found that 84percent of these patients were underinsured.

    The study authors noted that black patients had more advanced breast cancer atdiagnosis and poorer cancer-specific survival outcomes than whites. But after adjusting for age,cancer stage and other factors, they found that race was no longer significantly associated withbreast cancer-related death.

    In addition, contrary to previous study findings, black women were as likely as whitewomen to opt for breast-conserving procedures and "adjuvant" therapy, which is therapy givenafter the completion of the initial treatment -- such as chemotherapy, radiation or hormone therapy-- to lower the risk of cancer recurrence.

    "Despite the similar surgical care and adjuvant therapy, African American women in thisstudy had lower overall and breast cancer-specific survival compared with non-Hispanic whitewomen. After adjustment for competing causes of death, the survival disparity between AfricanAmerican and non-Hispanic white women appears to be attributable in part to differencesin clinical and socio-demographic factors between the groups," Dr. Ian K. Komenaka Socio-demographic factors include variables such as income, education level and access to health care,they explained.

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    6/30

    Mammography Use by Race

    Percent of American Women Over 40 Who Have Had a

    Mammogram Within Past 2 Years

    White

    Black, Non-HispanicHispanic

    American

    Indian/Alaska Native

    Asian American

    70.4%

    70.4%66.1%

    68.6%

    58.8%

    69.3%Source: American Cancer Society, 2005. Based on 2003 data.

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    7/30

    Risk of surviving cancer lessens with

    advanced stage, SEER 1975-2007Female Breast Cancer

    Stage5-year Relative

    Survival Rate

    0 100%

    I 100%

    IIA 92%

    IIB 81%IIIA 67%

    IIIB 54%

    IV 20%

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    8/30

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    9/30

    Differences by Cancer site

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    10/30

    2003-07 Major Cancer SitesSource: SEER Cancer Statistics Review, 1975-2007

    Incidence*

    Prostate 69.9

    Breast 66.5

    Lung & bronchus 62.5

    Colon & rectum 47.9

    Urinary Bladder 21.1

    Melanoma of the skin 20.1

    Non-Hodgkin Lymphoma

    19.6

    Mortality*

    Lung & bronchus 52.5

    Colon and rectum 17.6

    Breast 13.5

    Pancreas 10.7

    Prostate 9.5

    Leukemia 7.1

    Non-Hodgkin Lymphoma 6.9

    Liver & IBD 5.2 Ovary 4.8

    Esophagus 4.4

    *rate per 100,000 people, age adjusted to year 2000 standard

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    11/30

    Top 5 Cancer Mortality Sites by Race

    White: Lung & bronchus, colon &rectum, breast,pancreas, prostate

    Black: Lung & bronchus, colon &rectum, prostate,

    breast, pancreasAsian/Pacific Islander: Lung & bronchus, colon

    &rectum, liver & IBD, pancreas, stomach

    American Indian/Alaska Native: Lung & bronchus,

    colon &rectum, breast, pancreas, liver & IBDHispanic: Lung & bronchus, colon &rectum, breast,

    pancreas, liver &IBD

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    12/30

    2003-07 Major Cancer Mortality by SiteSource: SEER Cancer Statistics Review, 1975-2007

    Males*

    Lung & bronchus 68.8

    Prostate 24.7

    Colon & rectum 21.2

    Pancreas 12.3

    Leukemia 9.7

    Non-Hodgkin Lymphoma

    8.7

    Esophagus 7.8

    Female*

    Lung & bronchus 40.6

    Breast 24.0

    Colon and rectum 14.9

    Pancreas 9.4

    Ovary 8.6

    Non-Hodgkin Lymphoma

    5.5

    Uterine 4.1

    *rate per 100,000 people, age adjusted to year 2000 standard

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    13/30

    Cancer by Person, Place and

    Time

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    14/30

    Person, Place, Time

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    15/30

    Cancer death rates per 100,000

    population, Europe & US#1 Netherlands:433# 2 Italy:418

    # 3 Hungary:411

    # 4 Luxembourg:409.7

    # 5 Slovakia:405.3

    # 6 Ireland:357.6

    # 7 Czech Republic:335.4

    # 8 New Zealand:327.3

    # 9 United States:321.9

    # 10 Australia:298.9

    http://www.nationmaster.com/graph/hea_dea_fro_can-health-death-from-cancer , OECD 2004

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    16/30

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    17/30

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    18/30

    Risk of developing cancer

    increases with ageProbability of Developing Breast Cancer

    Within the Next 10 years

    By age 20

    By age 30By age 40

    By age 50

    By age 60

    By age 70

    Lifetime

    1 out of 1,760

    1 out of 2291 out of 69

    1 out of 42

    1 out of 29

    1 out of 27

    1 out of 8

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    19/30

    Person: Race, Ethnicity, Gender

    Breast Cancer Death Rates by Race

    Race/Ethnicity Female

    All Races

    WhiteBlack

    Asian/Pacific Islander

    American Indian/Alaska Native

    Hispanic

    25.5 per 100,000 women

    25.0 per 100,000 women33.8 per 100,000 women

    12.6 per 100,000 women

    16.1 per 100,000 women

    16.1 per 100,000 women

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    20/30

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    21/30

    Key Determinants of

    Disparities

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    22/30

    Key Determinants of Disparities

    James, SA Epidemiologic Reviews 31(1):1-6

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    23/30

    Prostate Cancer Incidence

    and Death Rates

    Racial/Ethnic Group Incidence Death

    All 168.0 27.9

    African American/Black 255.5 62.3

    Asian/Pacific Islander 96.5 11.3

    Hispanic/Latino 140.8 21.2

    American Indian/Alaska

    Native

    68.2 21.5

    White 161.4 25.6

    Statistics are for 2000-2004, age-adjusted to the 2000 U.S. standard million population, and

    represent the number of new cases of invasive cancer and deaths per year per 100,000 men.*

    http://www.cancer.gov/cancertopics/factsheet/disparities/cancer-health-disparities

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    24/30

    Key Determinants of Disparities

    Prostate Cancer and African Americans

    James, SA Epidemiologic Reviews 31(1):1-6

    B>W

    Obesity

    Diet

    B>W

    B>WPSA use

    B>W

    Cancer

    Incidence

    B>W

    GSTP1

    RAR2

    SPARCTIMP3

    NKX2-5 B>W

    B=W

    B=WTX Outcomes

    Red: worse, orange: same as, and green: better.

    Data issues and sources

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    25/30

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    26/30

    Data Issues and Sources

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    27/30

    Cancer graphics/tables will have:

    Caveats about the statistics

    Source of data

    Data availability issues How and when it was created

    For example, due to data availability issues,the time period used in the calculation ofthe joinpoint regression model may differfor selected racial groups or counties.

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    28/30

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    29/30

    Surveillance epidemiology and End Results(NCI) Racial/Ethnic Patterns of Cancer in

    the United States, 1988-1992

    http://seer.cancer.gov/publications/ethnicity/

  • 8/7/2019 Cancer and Minorities (Norma Kanarek, PhD, MPH)

    30/30

    Cancer Control P.L.A.N.E.T.

    State Cancer Profiles

    Research seminars Partners in Cancer Control

    General information by cancer topic